Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Brianna Rivest"'
Autor:
Benjamin Cuiffo, Melissa Maxwell, Dingxue Yan, Ramdane Guemiri, Andrew Boone, Deborah Bellet, Brianna Rivest, James Cardia, Caroline Robert, Simon P. Fricker
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
ObjectiveImmunotherapeutic inhibition of PD-1 by systemically administered monoclonal antibodies is widely used in cancer treatment, but it may cause severe immune-related adverse events (irSAEs). Neoadjuvant PD-1 inhibition before surgery has shown
Externí odkaz:
https://doaj.org/article/4c11e064c3e94d87ae9030c00767206b
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/df3f03f851424097b9b6f793b7d521f0
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/727d8d5895e94cad9f5a15fe468bc72c
Autor:
Shenghua Zhou, Benjamin Cuiffo, Melissa Maxwell, Dingxue Yan, Brianna Rivest, Andrew Boone, James Cardia, Simon Fricker
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Benjamin Cuiffo, Melissa Maxwell, Dingxue Yan, Brianna Rivest, Andrew Boone, Shenghua Zhou, James Cardia, Simon Fricker
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Melissa Maxwell, Dingxue Yan, Brianna Rivest, Andrew Boone, Shenghua Zhou, Benjamin Cuiffo, James Cardia, Simon Fricker
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Benjamin Cuiffo, Melissa Maxwell, Dingxue Yan, Andrew Boone, Brianna Rivest, Shenghua Zhou, James Cardia, Simon Fricker
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Benjamin G. Cuiffo, Andrew Boone, Dingxue Yan, Melissa Maxwell, Brianna Rivest, James Cardia, Simon P. Fricker
Publikováno v:
Cancer Research. 83:5113-5113
Combination immune checkpoint inhibition (ICI) with antibodies targeting PD-1 and CTLA-4 provides superior outcomes compared to either monotherapy alone. This combination has been approved for advanced melanoma, metastatic colon cancer and others. Ho
Autor:
Benjamin Cuiffo, Melissa Maxwell, Dingxue Yan, Shenghua Zhou, Brianna Rivest, Andrew Boone, James Cardia, Simon P. Fricker
Publikováno v:
Cancer Research. 82:4237-4237
Immune checkpoint inhibitor (ICI) anti-PD-1 antibody (mAb) monotherapy represented a significant advancement in cancer treatment, however most patients will ultimately progress, signaling the need for improvement. Combination approaches with other IC
Autor:
Dingxue Yan, Benjamin G. Cuiffo, Melissa Maxwell, James Cardia, Brianna Rivest, Simon Fricker
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundThe development of locally administered immune checkpoint inhibition (ICI) holds potential promise for enhanced activity and decreased systemic toxicity, but such an approach is challenging with the available ICI antibodies. We have previou